Individual responses to medication can vary, and your doctor can help weigh the benefits and risks specific to your situation
Keywords: Diabetes, Glucagon-like peptide-1 receptor agonist, Pharmacokinetics, Randomised controlled trial, Semaglutide, Steady state exposure Key Summary Points Digital Features This article is published with digital features, including a summary slide, to facilitate understanding of the article
Real-world cohort data further grounds these expectations
Your doctor will monitor your progress and adjust the dosage accordingly
The clinical expert consulted by CADTH on this review was clear that the term prediabetes, using the Diabetes Canada definition, is widely accepted in their field of practice in the Canadian context
Maria Dorotia Borges-Santos, Fernando Moreto, Paulo Camara Pereira, Yong-Ming Yu - Plasma glutathione of HIV+ patients responded positively and differently to dietary supplementation with cysteine or glutamine - Nutrition - Jul 2012